B. Brommer, O. Engel, and M. A. Kopp, Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level, Brain, vol.139, pp.692-707, 2016.

K. S. Held and T. E. Lane, Spinal cord injury, immunodepression, and antigenic challenge, Semin Immunol, vol.26, pp.415-420, 2014.

T. Riegger, S. Conrad, and K. Liu, Spinal cord injury-induced immune depression syndrome (SCI-IDS), Eur J Neurosci, vol.25, pp.1743-1747, 2007.

A. Roquilly, P. Seguin, and O. Mimoz, ATLANREA Study Group: Risk factors for prolonged duration of mechanical ventilation in acute traumatic tetraplegic patients-a retrospective cohort study, J Crit Care, vol.29, pp.313-320, 2014.

T. Riegger, S. Conrad, and H. J. Schluesener, Immune depression syndrome following human spinal cord injury (SCI): A pilot study, Neuroscience, vol.158, pp.1194-1199, 2009.

K. M. Lucin, V. M. Sanders, and T. B. Jones, Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation, Exp Neurol, vol.207, pp.75-84, 2007.

Y. Zhang, Z. Guan, and B. Reader, Autonomic dysreflexia causes chronic immune suppression after spinal cord injury, J Neurosci, vol.33, pp.12970-12981, 2013.

S. G. Muehlstedt, M. Lyte, and J. L. Rodriguez, Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia, Shock, vol.17, pp.443-450, 2002.

J. Zha, A. Smith, and S. Andreansky, Chronic thoracic spinal cord injury impairs CD8+ T-cell function by up-regulating programmed cell death-1 expression, J Neuroinflammation, vol.11, p.65, 2014.

A. H. Sharpe and G. J. Freeman, The B7-CD28 superfamily, Nat Rev Immunol, vol.2, pp.116-126, 2002.

M. E. Keir, M. J. Butte, and G. J. Freeman, PD-1 and its ligands in tolerance and immunity, Annu Rev Immunol, vol.26, pp.677-704, 2008.

R. V. Parry, J. M. Chemnitz, and K. A. Frauwirth, CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, Mol Cell Biol, vol.25, pp.9543-9553, 2005.

N. A. Hutchins, J. Unsinger, and R. S. Hotchkiss, The new normal: Immunomodulatory agents against sepsis immune suppression, Trends Mol Med, vol.20, pp.224-233, 2014.

R. S. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach, Lancet Infect Dis, vol.13, pp.260-268, 2013.

P. Brahmamdam, S. Inoue, and J. Unsinger, Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis, J Leukoc Biol, vol.88, pp.233-240, 2010.

K. C. Chang, C. A. Burnham, and S. M. Compton, Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis, Crit Care, vol.17, p.85, 2013.

C. Jacqueline, A. Broquet, and A. Roquilly, Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages, J Infect Dis, vol.210, pp.814-823, 2014.

A. Roquilly, L. Gautreau, and J. P. Segain, CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia, PLoS One, vol.5, p.13228, 2010.

A. Broquet, A. Roquilly, and C. Jacqueline, Depletion of natural killer cells increases mice susceptibility in a pseudomonas aeruginosa pneumonia model, Crit Care Med, vol.42, pp.441-450, 2014.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods, vol.25, pp.402-408, 2001.

M. Cella, A. Engering, and V. Pinet, Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells, Nature, vol.388, pp.782-787, 1997.

A. Roquilly, A. Broquet, and C. Jacqueline, Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage, Crit Care Med, vol.42, pp.752-761, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01601499

A. J. Zajac, J. N. Blattman, and K. Murali-krishna, Viral immune evasion due to persistence of activated T cells without effector function, J Exp Med, vol.188, pp.2205-2213, 1998.

S. D. Blackburn, H. Shin, and W. N. Haining, Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection, Nat Immunol, vol.10, pp.29-37, 2009.

S. L. Topalian, F. S. Hodi, and J. R. Brahmer, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N Engl J Med, vol.366, pp.2443-2454, 2012.

V. Failli, M. A. Kopp, and C. Gericke, Functional neurological recovery after spinal cord injury is impaired in patients with infections, Brain, vol.135, pp.3238-3250, 2012.

C. Meisel, J. M. Schwab, and K. Prass, Central nervous system injuryinduced immune deficiency syndrome, Nat Rev Neurosci, vol.6, pp.775-786, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00088273

C. P. Cardozo, Respiratory complications of spinal cord injury, J Spinal Cord Med, vol.30, pp.307-308, 2007.

D. L. Barber, E. J. Wherry, and D. Masopust, Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, vol.439, pp.682-687, 2006.

C. L. Day, D. E. Kaufmann, and P. Kiepiela, PD-1 expression on HIVspecific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.443, pp.350-354, 2006.

, Wherry EJ: T cell exhaustion, Nat Immunol, vol.12, pp.492-499, 2011.

J. S. Boomer, K. To, and K. C. Chang, Immunosuppression in patients who die of sepsis and multiple organ failure, JAMA, vol.306, pp.2594-2605, 2011.

A. Yao, F. Liu, and K. Chen, Programmed death 1 deficiency induces the polarization of macrophages/microglia to the M1 phenotype after spinal cord injury in mice, Neurotherapeutics, vol.11, pp.636-650, 2014.

E. Ramelyte, S. A. Schindler, and R. Dummer, The safety of anti PD-1 therapeutics for the treatment of melanoma, Expert Opin Drug Saf, vol.16, pp.41-53, 2017.

P. A. Ott, F. S. Hodi, and C. Robert, CTLA-4 and PD-1/PD-L1 blockade: New immunotherapeutic modalities with durable clinical benefit in melanoma patients, Clin Cancer Res, vol.19, pp.5300-5309, 2013.

J. Villadolid and A. Amin, Immune checkpoint inhibitors in clinical practice: Update on management of immune-related toxicities, Transl Lung Cancer Res, vol.4, pp.560-575, 2015.

D. I. Godfrey, S. Stankovic, and A. G. Baxter, Raising the NKT cell family, Nat Immunol, vol.11, pp.197-206, 2010.

S. Ivanov, C. Paget, and F. Trottein, Role of non-conventional T lymphocytes in respiratory infections: The case of the pneumococcus, PLoS Pathog, vol.10, p.1004300, 2014.

C. Paget and F. Trottein, Role of type 1 natural killer T cells in pulmonary immunity, Mucosal Immunol, vol.6, pp.1054-1067, 2013.

C. H. Wong, C. N. Jenne, and W. Y. Lee, Functional innervation of hepatic iNKT cells is immunosuppressive following stroke, Science, vol.334, pp.101-105, 2011.

M. Yamada, J. C. Gomez, and P. E. Chugh, Interferon-? production by neutrophils during bacterial pneumonia in mice, Am J Respir Crit Care Med, vol.183, pp.1391-1401, 2011.